Suchergebnisse - "Shachar, Eliya"

PubPharm (20)

11

The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2021

von Bar, Y. | Bar, K. | Itzhak, I. | +8

12

Pathology Consultation Clinic for Patients With Cancer : Meeting the Clinician Behind the Microscope

enthalten in: JCO oncology practice | 2021

von Shachar, E. | P Hasson, S. | Fayngor, R. | +2

13

Cancer Therapeutics-related Cardiac Dysfunction in Patients Treated With Immune Checkpoint Inhibitors : An Understudied Manifestation

enthalten in: Journal of immunotherapy (Hagerstown, Md. : 1997) | 2021

von Peleg Hasson, S. | Arnold, J. | Merdler, I. | +12

14

Rapid Implementation of Telemedicine During the COVID-19 Pandemic : Perspectives and Preferences of Patients with Cancer

enthalten in: The oncologist | 2021

von Hasson, S. | Waissengrin, B. | Shachar, E. | +8

15

Kambô-Induced Systemic Inflammatory Response : A Case Report of Acute Disease Progression of Cholangiocarcinoma

enthalten in: Integrative cancer therapies | 2021

von Peleg Hasson, S. | Shachar, E. | Kessner, R. | +2

16

Rapid Implementation of Telemedicine During the COVID‐19 Pandemic : Perspectives and Preferences of Patients with Cancer

enthalten in: The oncologist | 2021

von Hasson, S. | Waissengrin, B. | Shachar, E. | +8

17

R269C variant of ESR1 : high prevalence and differential function in a subset of pancreatic cancers

enthalten in: BMC cancer | 2020

von Boldes, T. | Merenbakh-Lamin, K. | Journo, S. | +6

18

R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers

enthalten in: BMC cancer | 2020

von Boldes, T. | Merenbakh-Lamin, K. | Journo, S. | +6

19

R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers

enthalten in: BMC cancer | 2020

von Boldes, T. | Merenbakh-Lamin, K. | Journo, S. | +6

20

Unusually long-term responses to vemurafenib in BRAF V600E mutated colon and thyroid cancers followed by the development of rare RAS activating mutations

enthalten in: Cancer biology & therapy | 2018

von Ofir Dovrat, T. | Sokol, E. | Frampton, G. | +4